Evaluating two concentrations of bupivacaine for pain relief in hip surgery
Evaluation of the Effectiveness of Two Different Bupivacaine Concentrations of Ultrasound-guided Postoperative PENG Block in Hip Operations Performed With Spinal Anesthesia
NA · Abant Izzet Baysal University · NCT05921110
This study tests whether two different strengths of bupivacaine can provide better pain relief for people having hip surgery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 66 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Abant Izzet Baysal University (other) |
| Locations | 2 sites (Bolu and 1 other locations) |
| Trial ID | NCT05921110 on ClinicalTrials.gov |
What this trial studies
This study assesses the effectiveness of two different concentrations of bupivacaine used in the Pericapsular Nerve Group (PENG) block for patients undergoing hip surgery. The PENG block is a regional anesthesia technique aimed at providing effective pain relief while sparing motor function. By comparing the analgesic requirements and pain levels between the two concentrations, the study aims to optimize postoperative pain management in hip fracture surgeries. The use of ultrasound guidance enhances the precision and safety of the nerve block administration.
Who should consider this trial
Good fit: Ideal candidates include patients classified as ASA I-III who are scheduled for hip surgery.
Not a fit: Patients with contraindications for regional blocks, such as coagulopathy or infection at the injection site, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing hip surgery, reducing reliance on opioids.
How similar studies have performed: Other studies have shown success with similar regional anesthesia techniques, indicating a promising approach to postoperative pain management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA I- III risk undergoing hip surgery. Exclusion Criteria: * Contraindications for regional blocks (eg. patient refusal, coagulopathy, infection at the injection site), allergic reaction to local anesthetics and other analgesics.
Where this trial is running
Bolu and 1 other locations
- Bolu Abant İzzet Baysal Medical School — Bolu, Turkey (RECRUITING)
- Bolu Abant İzzet Baysal University Faculty of Medicine — Bolu, Turkey (RECRUITING)
Study contacts
- Principal investigator: Fatma Saridemir — Bolu Abant İzzet Baysal Medical School
- Study coordinator: Ilker Ital
- Email: ilkerital@gmail.com
- Phone: +905337723300
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hip Fractures, Postoperative Pain, PENG Block, Hip Surgery